Imagine gaining hands-on skills in vaccine manufacturing while helping Africa build its own health future. The Africa CDC & AVMI Industrial Fellowship Programme 2026-2027 offers recent African graduates a fully funded chance to do just that. This one-year program trains just 14 fellows in real vaccine factories across the continent.
Background and Need for the Program
Africa needs more experts in vaccine production. By 2040, the continent will require about 12,500 full-time workers in this field. Right now, only 2,000 to 3,000 people fill these roles, and many lack full training.
Past training abroad cost too much and faced visa issues. Africa also lacks enough local spots for practical work. To fix this, Africa CDC teamed up with the African Vaccine Manufacturing Initiative (AVMI) to create this fellowship. It builds skills right on the continent.
Program Overview
This fellowship runs from July 2026 to September 2027. Fellows work in vaccine plants in Egypt, Senegal, or South Africa. The training matches Africa CDC’s standards for vaccine research, development, and manufacturing. It stresses current Good Manufacturing Practices (cGMP), which ensure safe production.
Key Features
- Duration: 12 months of full-time training.
- Locations: Three host countries with active facilities.
- Focus: Real-world vaccine making and quality standards.
- Spots Available: Limited to 14 fellows for close mentoring.
Benefits for Fellows
Fellows get full support to focus on learning.
Financial Help
- Round-trip flights to the host country.
- Visa and document costs covered.
- Monthly stipend for daily needs.
Practical Training
Work in actual factories to learn production steps. See how vaccines move from lab to shelf under global rules.
Career Boost
Build skills employers want. Gain experience that leads to jobs in biotech and public health. Help Africa’s vaccine goals.
Eligible Fields of Study
You need a degree from the last three years in:
- Pharmacy or Pharmaceutical Sciences
- Pharmaceutical Biotechnology
- Chemistry or Biochemistry
- Chemical Engineering
- Biomanufacturing or Vaccine Manufacturing
Who Can Apply
Meet these rules:
- Citizen of an African Union country.
- Bachelor’s or Master’s graduate (within 3 years).
- Valid passport.
- Free to join in Egypt, Senegal, or South Africa.
- Good in English or French.
All backgrounds welcome. Women get special encouragement to apply.
How Selection Works
A team from Africa CDC, PHAHM, and AVMI reviews applications. They pick shortlisted candidates. Only contacts go to those selected. Final choice: 14 fellows.
Important Dates
- Deadline: April 30, 2026
- Results: May 15, 2026
- Start/End: July 2026 to September 2027
Apply soon for better odds.
Steps to Apply
Fill the online form here: Apply for the Africa CDC Industrial Fellowship Programme
More details at Africa CDC and AVMI page.
Reasons to Join
This program gives rare factory experience in Africa. You learn key skills in a growing field. It boosts your resume for biotech jobs. Plus, you aid Africa’s health security. Be part of the next wave of vaccine leaders.
Conclusion
The Africa CDC & AVMI Industrial Fellowship Programme 2026-2027 opens doors for African graduates to shape vaccine production on the continent. With full funding and real training, it meets a key need. Apply by April 30, 2026, and take this step toward a strong career.
SHARE THIS POST WITH OTHERS
Frequently Asked Questions
Who is eligible for the Africa CDC & AVMI Industrial Fellowship?
African Union citizens with a Bachelor’s or Master’s degree from the last three years in fields like pharmacy, biotechnology, chemistry, or chemical engineering.
What financial support does the program provide?
It covers round-trip flights, visa costs, and a monthly stipend for living expenses.
When is the application deadline and program start date?
Applications close on April 30, 2026, with results by May 15, 2026, and the program starts in July 2026.
Where will fellows receive their training?
Fellows train in vaccine manufacturing plants in Egypt, Senegal, or South Africa.
Conversation
0 Comments